Veerle Mondelaers
Show
Sort by
-
Cost-minimisation of PEG-L-asparaginase versus native L-asparaginase for the treatment of children with acute lymphoblastic leukemia in Belgium
-
PEG-asparaginase in treatment of childhood acute lymphoblastic leukemia
-
Musculoskeletal manifestations in children with acute lymphoblastic leukaemia
-
Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood
-
Screening for hereditary spherocytosis in routine practice : evaluation of a diagnostic algorithm with focus on non-splenectomised patients
-
Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia
-
Hemifacial paralysis in a child treated for leukemia: unusual side effect of omeprazole?
-
Methemoglobinemia and hemolytic anemia caused by Rasburicase administration in a child with acute lymphoblastic leukemia
-
Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951
-
Asparaginase levels, antibodies and silent inactivation in childhood acute lymphoblastic leukemia